DKK1 and neoplasm: In conclusion, we found that DKK1 inhibition significantly enhanced the anti-tumor efficacy of SOR by inhibiting the PI3K/Akt and Wnt/β-catenin pathways and both pathways were connected via GSK3β in HCC.